Comparing venlafaxine extended release and fluoxetine for preventing the recurrence of major depression: results from the PREVENT study.

@article{Thase2011ComparingVE,
  title={Comparing venlafaxine extended release and fluoxetine for preventing the recurrence of major depression: results from the PREVENT study.},
  author={Michael E. Thase and Alan J. Gelenberg and Susan G. Kornstein and James Howard Kocsis and Madhukar H. Trivedi and Philip T Ninan and Thomas Sing Tao Li and Ronald D. Pedersen and Martin B. Keller},
  journal={Journal of psychiatric research},
  year={2011},
  volume={45 3},
  pages={412-20}
}
This secondary analysis from the Prevention of Recurrent Episodes of Depression with Venlafaxine Extended Release (ER) for Two Years (PREVENT) study compared the efficacy of venlafaxine ER and fluoxetine for the prevention of recurrence in patients with a history of recurrent major depressive disorder (MDD). Patients received double-blind treatment with… CONTINUE READING